Legalized marijuana has a lot of investors having visions of lots of green. With legalization sweeping across the states, it seems to be a great time to invest in marijuana stocks. Unfortunately, it’s not.
Tag Archives: Company
ALBUQUERQUE, Feb. 8, 2018 /Weed Wire/ — New Mexico’s Medical Cannabis Program ended January 2018 with 47,840 enrolled patients according to the New Mexico Department of Health report, a 49 percent increase over the same month in 2017.
Anticipation is building for GW Pharmaceuticals (NASDAQ:GWPH) as the biotech prepares to hopefully launch its first product in the U.S. in 2018.
State regulators awarded a $1 million, three-year contract this week to a New Jersey-based company to operate a toll-free help line for patients, caregivers and doctors accessing Ohio’s new medical marijuana program.
Canadian cannabis company Aphria Inc said on Thursday it was exploring strategic alternatives, including a sale, for its U.S. business, amid tightening enforcement of federal cannabis laws in the country.
Not only do the rules for marijuana consumption vary from state to state, but so do the prices. From coast to coast, marijuana prices in the United States range from just over $7 in the west to nearly $18 in the east.
Celebrities who flaunted their pot smoking for decades when it was taboo are now cashing in on the legal cannabis boom.
The largest U.S. auto-dealer chain has lightened up on lighting up. AutoNation Inc. no longer refuses to hire job applicants who test positive for marijuana in drug screenings.
Licensed marijuana producer Aphria Inc. announced an agreement Monday to buy medical cannabis firm Nuuvera Inc. in a cash-and-stock deal that it says values the company at $826 million.
A U.S. private equity firm investing exclusively in legal cannabis said on Thursday it had raised more than $100 million in its third round of fundraising, underscoring investor appetite for the burgeoning industry.
This month California became the largest U.S. state to sell recreational marijuana. As sellers pop up all over America, business opportunities are also developing.
Florida tech firm Spring Big builds customer loyalty program software for pot shops, many in California.
A Canadian dog-treat maker wants to produce a different kind of munchie. True Leaf Medicine International Ltd., a small firm that currently produces hemp-based dog chews, is expanding into the nation’s fast-emerging marijuana industry.
The fledgling cannabis industry is full of wide-eyed claims about what pot can do. Outperform your favorite energy drink? Maybe. Cure cancer? Worth a try. The biggest believers and entrepreneurs make the plant sound almost magical.
Lord Jones co-founder Cindy Capobianco describes her luxury cannabis-infused product business in much the same manner as any maker of a prestige natural skincare brand.
ALBUQUERQUE, Jan 5., 2018 /Weed Wire/ — Patient enrollment in New Mexico’s Medical Cannabis Program hit 46,645 as of December 31, 2017, finishing the year with a 61 percent increase over the January 1, 2017 cardholder numbers. The New Mexico medical program appears to be growing at nearly twice the pace of neighboring Arizona.
A Canadian company plans to launch a large, industrial hemp operation in northern Maine this year in the latest sign of burgeoning interest in the versatile yet tightly regulated crop.
All it took was a little marijuana to lift this Canadian town’s spirits. Smiths Falls, Ontario is seeing a revival of fortunes since medical marijuana producer Tweed Inc. set up shop four years ago in an abandoned Hershey Co. chocolate factory.
Medical marijuana maker Aphria Inc said on Thursday it would invest C$10 million ($7.80 million) in the proposed combination of two recreational marijuana companies to expand its presence in the sector.
A San Diego marijuana company is offering up advice to local residents who are looking to properly grow their own marijuana.
Canada’s Canopy Growth Corp said it would form a joint venture with privately owned Canopy Rivers Corp and Quebec-based tomato producer Les Serres Stéphane Bertrand to grow cannabis in a tomato greenhouse.
One oft-cited statistic about the cannabis space claims that women hold 36% of leadership positions in the industry, higher than the 22% average across all U.S. businesses.
Medical marijuana company Aurora Cannabis Inc said on Monday its acquisition-target CanniMed Therapeutics Inc’s plan to buy smaller rival Newstrike Resources Ltd was a “terrible deal” for CanniMed shareholders.
You like wine. You like weed. But how do you feel about weed wine? As perplexing as that might sound, it’s actually something adults living in legal marijuana states will be able to sip on.
TheraCann USA Benchmark has abandoned plans to build a $20 million medical marijuana facility in Kingsley. Richard Goodman, president of TheraCann USA, confirmed the decision on Wednesday, Dec. 13.
Aurora Cannabis has launched the first ever “hostile” takeover of another ACMPR Licensed Producer of Medical Marijuana. Executive Vice President Cam Battley lays out the case for why CanniMed shareholders should tender their shares to the Aurora bid.
Medicinal marijuana stores are finally beginning to open after Maryland legalized the substance in 2013, and a California-based company is helping make that transition smoother.
Canada’s Aurora Cannabis Inc (ACB.TO) said on Monday it increased its stake in Australia-based Cann Group Ltd (CAN.AX) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.
Over the past year, investors have been anxiously following the progression of marijuana stocks such as Canopy Growth Corp, which offer the promise of significant growth from the new, emerging segment of the economy.
A Vancouver cannabis company is scrambling to keep up with a flood of orders for marijuana-filled advent calendars, but the novel take on a popular Christmas tradition has some health experts ringing alarms.
Barely a month after being ousted as head of the cannabis social network he launched in 2013, MassRoots founder Isaac Dietrich is now being sued by his former company, which alleges he stole more than $250,000 from the business.
A medical marijuana company in New York is looking to start the holiday shopping season off on a high note with a Cyber Monday deal on weed.
Say hello to the very first marijuana ETF for the U.S. As reported by CNBC, on Oct. 27, ETF Managers Group filed for a new ETF, the Alternative Agroscience ETF.
Not surprisingly, Canadian pot stocks have been the top performers of late, with Canopy Growth Corp. (NASDAQOTH:TWMJF), the now-largest marijuana stock in the world by market cap, leading the charge.
Vancouver-based Aurora Cannabis Inc. said Tuesday that it has made an all-share offer for CanniMed Therapeutics Inc., a fellow Canadian medical marijuana company.
IBM Corp., one of the bluest of U.S. blue-chip companies, is touting blockchain as the supply-management tool of choice for an unusual industry — cannabis.
Making it easier to calibrate the correct dose of medical marijuana may prompt more physicians to prescribe it as an alternative to a painkiller such as opioids, according to one Canadian company.
Shares of Canopy Growth Corp. (TSX:WEED) have climbed a stunning 53.8% month over month as of close on November 1. With all of this in mind, has Canopy established itself as the premier cannabis stock for Canadians?
Cannabis businesses licensed by the State of California may now purchase commercial insurance coverage from an admitted commercial insurance company. Insurance Commissioner Dave Jones has approved the filing of the first admitted commercial insurance company to file cannabis business insurance, so that the insurer can begin writing policies and offering coverage for cannabis business owners.
A new tech company has set it sight on making the growing marijuana industry safer. The main goal is to reduce the amount of cash transactions.
The Auscann Group Holdings Ltd (ASX: AC8) share price had a day to remember on Tuesday. At one stage the medicinal cannabis company’s shares were up as much as 27% before finishing the day 23.5% higher at 52.5 cents.
Shares of Insys Therapeutics, a small-cap biotech with a focus on pain management, plunged as much as 30% on Wednesday after receiving a double whammy.
Retired NBA player Al Harrington takes us behind the doors of his cannabis extract company, then sits down with former NBA commissioner David Stern to discuss marijuana reformation for medical purposes within the league.
Knowledge Keiretsu caught up with professional investors Sturges Karban and Urban Smedeby, MJIC, Inc., a Los Angeles-based full-service cannabis company, to get their thoughts on navigating the opportunities and challenges of investing in the legal cannabis market.
The high-growth industry certainly offers terrific prospects that would be envied by many tech stocks. However, a big hurdle for some investors is investing in “sin stocks,” or what could be perceived as unethical industries and businesses.
For the past two years, Michael Zaytsev has sold tickets to the New York Cannabis Film Festival on Eventbrite. But this year, Eventbrite abruptly pulled the event from its platform and suspended Zaytsev’s account.
Shares of Canadian marijuana company Aphria Inc sank on Tuesday, after the operator of the Toronto Stock Exchange said cannabis companies with U.S. interests would come under heightened scrutiny and could be delisted.
The stock of MedReleaf Corp. has recently outperformed those of other top marijuana stock players in Canada, and there could be further price gains going forward after the recently listed cannabis firm has found its footing and stopped the earlier quarterly revenue declines.
Legal pot sales rose a stunning 34% in 2016 to $6.7 billion across North America, according to Arcview Market Research. But with growth this rapid, there’s bound to be more than a few marijuana stock investments that will be left behind.
Marijuana companies should be careful in overselling how much growth will be achieved or what the prospects will look like for the industry. There is a recent example that cannabis investors would be wise to review, and that’s what happened with Freshii Inc..
After the company announced it will tap investors for money to fuel R&D (research and development) and pre-commercialization efforts for its Dravet syndrome drug, shares in Zogenix (NASDAQ: ZGNX) are rallying 10% at 2 p.m. EDT today.